Literature DB >> 17316543

The use of intravenous catheterisation with a rest period is useful for determination of plasma cortisol levels but not plasma prolactin levels.

C Briet1, M Saraval, S Loric, H Topolinski-Duyme, S Fendri, R Desailloud.   

Abstract

OBJECTIVE: The use of an intravenous catheter with a rest period has been recommended to avoid false-positive results for hyperprolactinaemia and false-negative results for hypocortisolaemia. We tested the relevance of this recommendation.
DESIGN: Plasma cortisol and prolactin levels were determined before (T-15) and after a 15-min rest period (T0) in 119 patients, 38 males (M) and 81 females (F). 52 of the 119 patients were known (K; 30 females and 22 males) and 67 unknown (UK; 49 females and 18 males) to the unit.
RESULTS: Prolactin was lower after rest in women (12.3+/-22.7 ng/l vs 11.7+/-22.5 ng/ml, P=0.03), but not in men (6.2+/-4.5 ng/ml at T-15 vs 5.8+/-3.2 ng/ml at T0, P=0.09), in the UK subgroup (10.6+/-20.7 ng/ml at T-15 vs 10.1+/-20.9 ng/ml at T0, P=0.06) and in the K subgroup (10.1+/-16.7 ng/ml at T-15 vs 9.7+/-15.8 ng/ml at T0, P=0.08). None of the patients with prolactin levels higher than 20 ng/ml at T-15 diminished its prolactin value below this cut-off value. Plasma cortisol levels were lower after rest in women (17.9+/-5.9 microg/dl at T-15 vs 16.5+/-6.1 microg/dl at T0, P<0.0001), in the UK subgroup (18+/-6.1 microg/dl at T-15 vs 16.6+/-6.4 microg/dl at T0, P=0.0003) but not in men (18+/-4.4 microg/dl at T-15 vs 17.5+/-5.8 microg/dl at T0, P=0.47) and in the K subgroup (17.8+/-4.6 microg/dl at T-15 vs 17+/-5.4 microg/dl at T0, P=0.13). At T0, 3.3% and 15% of patients presented values below the cut-off value of 10 microg/dl (276 nmol/l) and 17 microg/dl (470 nmol/l), respectively.
CONCLUSION: These results don't justify intravenous catheterisation with a rest period for plasma prolactin determination in contrast with plasma cortisol determination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316543     DOI: 10.1016/j.ando.2006.10.002

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  4 in total

1.  Importance of cannulated prolactin test in the definition of hyperprolactinaemia.

Authors:  M B Whyte; S Pramodh; L Srikugan; J A Gilbert; J P Miell; R A Sherwood; A M McGregor; S J B Aylwin
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

2.  Differential Effects of Estrogen on Corticosteroid-Binding Globulin Forms Suggests Reduced Cleavage in Pregnancy.

Authors:  Marni A Nenke; Anna Zeng; Emily J Meyer; John G Lewis; Wayne Rankin; Julie Johnston; Svjetlana Kireta; Shilpanjali Jesudason; David J Torpy
Journal:  J Endocr Soc       Date:  2017-02-13

3.  The utility of prolactin serial sampling and the best prolactin cut-offs associated with persistent hyperprolactinemia.

Authors:  Catarina Cidade-Rodrigues; Filipe M Cunha; Catarina Chaves; Margarida Silva-Vieira; André Silva; Susana Garrido; Mariana Martinho; Margarida Almeida
Journal:  Porto Biomed J       Date:  2021-04-13

4.  Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia.

Authors:  Raya Almazrouei; Shamaila Zaman; Florian Wernig; Karim Meeran
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2021-06-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.